Amedica

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Amedica and buy or sell other stocks, ETFs, and their options commission-free!

About AMDA

SINTX Technologies, Inc. is a ceramics company, which engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. 

CEO
Eric Kenneth Olson
CEOEric Kenneth Olson
Employees
Employees
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
1996
Founded1996
Employees
Employees

AMDA Key Statistics

Market cap
13.52M
Market cap13.52M
Price-Earnings ratio
-0.51
Price-Earnings ratio-0.51
Dividend yield
Dividend yield
Average volume
26.18K
Average volume26.18K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$7.36
52 Week high$7.36
52 Week low
$1.71
52 Week low$1.71

Stock Snapshot

With a market cap of 13.52M, Amedica(AMDA) trades at $0.94. The stock has a price-to-earnings ratio of -0.51.

During the trading day, Amedica(AMDA) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 26.18K.

The stock's 52-week range extends from a low of $1.71 to a high of $7.36.

The stock's 52-week range extends from a low of $1.71 to a high of $7.36.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.